Tradestie Institutional Equity Comparison Engine

NMTC vs AAPU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMTC Overall Edge

NMTC Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeuroOne Medical Technologies Corporation Common Stock (NMTC) driven by superior Growth & Margin, Options & Structure while AAPU counters with relative strength in Momentum & Technical. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus AAPU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AAPU sits in UNCLASSIFIED (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NMTC N/M vs AAPU N/M Fwd P/E
Growth & Margin Winner NMTC
Op Margin -63.4% vs N/A ยท YoY +16.3% vs N/A
Momentum & Technical Winner AAPU
1Y +3.5% vs +29.5% ยท 52W Pos 2% vs 79%
Options & Structure Winner NMTC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (11th %ile IV)
NMTC NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
1M Return -33.46%
1Y Return +3.49%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0
AAPU NASDAQ
Direxion Shares ETF Trust Direxion Daily AAPL Bull 2X Shares
Institutional Equity
$45.91
-3.71% 1D
Market Cap N/A
1M Return -4.35%
1Y Return +29.47%
Forward P/E N/M
Unified AI Score
54.2 / 100 HOLD
Tech 42.0 Fund 43.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMTC +3.49% AAPU +29.47% Spread: +25.98 pp (AAPU Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMTC TTM Op. Margin: -63.4% AAPU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMTC vs AAPU. Trailing 12-month operating profitability (NMTC -63.4% vs AAPU N/A) and valuation multiples (NMTC N/M vs AAPU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMTC (5) vs AAPU (3)
Institutional Metric NMTC AAPU Criterion Row Winner
Market Capitalization Scale $6.1M N/A Larger Scale NMTC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +16.3% N/A Higher Growth NMTC
Operating Margin (TTM) Profitability -63.4% N/A Higher Margin NMTC
Net Profit Margin Profitability -59.7% N/A Higher Margin NMTC
Return on Equity (ROE) Capital Efficiency -124.7% N/A Higher ROE NMTC
52-Week Range Position Momentum 2% ($1โ€“$5) 79% ($26โ€“$51) Stronger Trend AAPU
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 105% Vol 1.06ฮฒ ยท 54% Vol Lower Realized Risk AAPU
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 54.2 / 100 (HOLD) Higher Composite AAPU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMTC vs AAPU Buy Guide
NMTC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AAPU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live AAPU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMTC nor AAPU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.